Universal Ibogaine Stock Price Prediction
| IBOGF Stock | USD 0.01 0 22.22% |
Momentum 39
Sell Extended
Oversold | Overbought |
Using Universal Ibogaine hype-based prediction, you can estimate the value of Universal Ibogaine from the perspective of Universal Ibogaine response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Universal Ibogaine to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Universal because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Universal Ibogaine after-hype prediction price | USD 0.00723 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Universal |
Universal Ibogaine After-Hype Price Prediction Density Analysis
As far as predicting the price of Universal Ibogaine at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Universal Ibogaine or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Universal Ibogaine, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Universal Ibogaine Estimiated After-Hype Price Volatility
In the context of predicting Universal Ibogaine's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Universal Ibogaine's historical news coverage. Universal Ibogaine's after-hype downside and upside margins for the prediction period are 0.00 and 23.15, respectively. We have considered Universal Ibogaine's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Universal Ibogaine is out of control at this time. Analysis and calculation of next after-hype price of Universal Ibogaine is based on 3 months time horizon.
Universal Ibogaine Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Universal Ibogaine is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Universal Ibogaine backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Universal Ibogaine, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.18 | 23.14 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.01 | 0.01 | 31.45 |
|
Universal Ibogaine Hype Timeline
Universal Ibogaine is currently traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Universal is forecasted to increase in value after the next headline, with the price projected to jump to 0.00723 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is estimated to be 31.45%, whereas the daily expected return is currently at 2.18%. The volatility of related hype on Universal Ibogaine is about 0.0%, with the expected price after the next announcement by competition of 0.01. Universal Ibogaine has accumulated 1.74 M in total debt with debt to equity ratio (D/E) of 0.24, which may suggest the company is not taking enough advantage from borrowing. Universal Ibogaine has a current ratio of 2.35, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Universal Ibogaine until it has trouble settling it off, either with new capital or with free cash flow. So, Universal Ibogaine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Universal Ibogaine sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Universal to invest in growth at high rates of return. When we think about Universal Ibogaine's use of debt, we should always consider it together with cash and equity.Assuming the 90 days horizon the next forecasted press release will be uncertain. Check out Universal Ibogaine Basic Forecasting Models to cross-verify your projections.Universal Ibogaine Related Hype Analysis
Having access to credible news sources related to Universal Ibogaine's direct competition is more important than ever and may enhance your ability to predict Universal Ibogaine's future price movements. Getting to know how Universal Ibogaine's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Universal Ibogaine may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AGNPF | Algernon Pharmaceuticals | 0.00 | 0 per month | 6.84 | (0.01) | 14.41 | (14.26) | 31.25 | |
| RNUGF | ReNeuron Group Plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HESG | Health Sciences Gr | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ADXS | Ayala Pharmaceuticals | 0.00 | 0 per month | 21.69 | 0.21 | 122.19 | (53.64) | 734.55 | |
| APLIF | Appili Therapeutics | 0.00 | 0 per month | 7.36 | 0.01 | 20.00 | (16.67) | 42.48 | |
| NMLSF | Nova Mentis Life | 0.00 | 0 per month | 6.99 | 0.09 | 17.30 | (15.79) | 66.40 | |
| GRTX | Galera Therapeutics | 0.00 | 0 per month | 6.20 | 0.07 | 14.89 | (11.11) | 60.42 | |
| VGLS | Vg Life Sciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AAGH | America Great Health | 0.00 | 0 per month | 0.00 | (0.03) | 0.00 | 0.00 | 150.00 | |
| GENPF | Genix Pharmaceuticals | 0.00 | 2 per month | 0.00 | 0.12 | 0.00 | 0.00 | 121.14 |
Universal Ibogaine Additional Predictive Modules
Most predictive techniques to examine Universal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Universal using various technical indicators. When you analyze Universal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Universal Ibogaine Predictive Indicators
The successful prediction of Universal Ibogaine stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Universal Ibogaine, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Universal Ibogaine based on analysis of Universal Ibogaine hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Universal Ibogaine's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Universal Ibogaine's related companies.
Story Coverage note for Universal Ibogaine
The number of cover stories for Universal Ibogaine depends on current market conditions and Universal Ibogaine's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Universal Ibogaine is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Universal Ibogaine's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for Universal Pink Sheet analysis
When running Universal Ibogaine's price analysis, check to measure Universal Ibogaine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Ibogaine is operating at the current time. Most of Universal Ibogaine's value examination focuses on studying past and present price action to predict the probability of Universal Ibogaine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Ibogaine's price. Additionally, you may evaluate how the addition of Universal Ibogaine to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |